ADRIAN HOLMES: Open Payments
NPI 1992117402 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 88 payments from 15 companies in 2025. Trend: 2023 $653 · 2024 $1,981 · 2025 $1,611
Food & beverage: $1,611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $352 |
| Janssen Biotech, Inc. | 12 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $270 |
| Phathom Pharmaceuticals, Inc. | 18 | $196 |
| Ardelyx, Inc. | 6 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| PFIZER INC. | 3 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Celltrion USA Inc. | 2 | $42 |
| GENZYME CORPORATION | 2 | $42 |
Products named: TREMFYA, ENTYVIO, VOQUEZNA, SKYRIZI, IBSRELA, RINVOQ, CREON, XIFAXAN.
Industry payments across KY — which companies pay providers there.
